Adalimumab

Details

Files

Generic Name:

Adalimumab

Project Status:

Complete

Therapeutic Area:

Hidradenitis suppurativa

Manufacturer:

AbbVie Corporation

Call for patient/clinician input open:

September 30, 2015

Brand Name:

Humira

Project Line:

Reimbursement Review

Project Number:

SR0455-000

Call for patient/clinician input closed:

November 19, 2015

NOC Status at Filing:

Pre NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Hidradenitis suppurativa

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

May 19, 2016

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : September 13, 2018